Table 2.
Exploratory Factor Analysis Results (n = 44) and Internal consistency results for the Iranian context.
| Item | M | SD | CITC | Factors and Factor Loadings | ||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| Factor 1: knowledge about medication errors prevention | ||||||
| Dosage calculus of intravenous drug reduces preparation errors | 4.02 | 0.849 | 0.601 | 0.567 | 0.223 | 0.22 |
| Computerized provide order entry system (CPOE) reduce errors during the preparation’s phase | 4.05 | 0.861 | 0.684 | 0.627 | 0.272 | 0.237 |
| Provision of pre-packaged by the pharmacy reduces medication errors risk | 4.09 | 0.984 | 0.746 | 0.778 | 0.193 | 0.269 |
| Availability of informative protocols, posters and brochures in the wards, promotes the decrease of the error risk | 4.09 | 0.884 | 0.841 | 0.758 | 0.472 | 0.2 |
| Assistance of a pharmacist during drug preparation reduces the error risk | 4.16 | 0.914 | 0.778 | 0.762 | 0.315 | 0.222 |
| Alarm noises and ward emergencies may cause distractions during drugs preparation and administration | 4.09 | 0.960 | 0.789 | 0.806 | 0.307 | 0.208 |
| Workload (double shifts, extra time) contributes to pharmacological therapy errors | 4.34 | 0.963 | 0.765 | 0.666 | 0.171 | 0.485 |
| Following the 8 R rule (right patient, right medication, right dose, right route, right time, right documentation, right reason, right response) reduces errors | 4.05 | 1.056 | 0.675 | 0.445 | 0.453 | 0.292 |
| Factor 2: Attitude to medication errors prevention | ||||||
| Ongoing and specific training on safe management of IV drug could reduce the risk of errors | 2.80 | 0.408 | 0.557 | 0.23 | 0.405 | 0.405 |
| Awareness of the prevention of the errors and management of the clinical risk could reduce the errors during the preparation and administration phases of the drugs | 2.77 | 0.476 | 0.845 | 0.56 | 0.582 | 0.329 |
| The motivation of the workers can improve their professional performance during the whole medication process | 2.89 | 0.387 | 0.65 | 0.282 | 0.555 | 0.347 |
| For a secure management of the entire managing process of IV drugs, some authoritative guidelines drawn up taking into account the available scientific evidence are necessary | 2.82 | 0.446 | 0.669 | 0.295 | 0.737 | 0.201 |
| Protocols/guidelines/procedure can affect professional behaviour, ensuring proper management of therapeutic process | 2.77 | 0.476 | 0.747 | 0.333 | 0.806 | 0.236 |
| Clinical skills about safe management of drug therapy should be regularly evaluated | 2.80 | 0.462 | 0.716 | 0.228 | 0.899 | 0.237 |
| Medication errors should be reported in order to become an opportunity to improve the care service | 2.80 | 0.462 | 0.752 | 0.314 | 0.874 | 0.215 |
| Factor 3: Behaviour to medication errors prevention | ||||||
| Hand-washing is necessary before the drug preparation and administration | 4.23 | 0.743 | 0.803 | 0.386 | 0.265 | 0.85 |
| A check of vital signs before and after the vasoactive drug administration (dopamine, dobutamine, nitroglycerine, etc) reduces complications | 4.32 | 0.674 | 0.673 | 0.235 | 0.18 | 0.892 |
| Respecting the speed of infusion of the IV administrated solutions (such as chemotherapy, antibiotics, amines, heparin, etc) reduces errors | 4.36 | 0.780 | 0.736 | 0.296 | 0.292 | 0.807 |
| Before administration, it is necessary to perform a double check to verify the right correspondence among prescription, preparation and administration of the IV drug | 4.45 | 0.627 | 0.749 | 0.279 | 0.443 | 0.677 |
| Eingevalue | 11.070 | 1.634 | 1.540 | |||
| Percentage of variance explained | 25.950 | 25.121 | 20.250 | |||